Inhibition of STAT5: A therapeutic option in BCR-ABL1-driven leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibition of STAT5: A therapeutic option in BCR-ABL1-driven leukemia

Published:2014-10-09 Issue:20 Volume:5 Page:9564-9576
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Berger Angelika¹,Sexl Veronika¹,Valent Peter²,Moriggl Richard³

Affiliation:

1. Institute of Pharmacology and Toxicology, University of Veterinary Medicine, Vienna, Austria

2. Department of Medicine I, Division of Hematology and Ludwig-Boltzmann Cluster Oncology, Medical University of Vienna, Austria

3. Ludwig-Boltzmann Institute for Cancer Research, University of Veterinary Medicine, Medical University Vienna, Austria

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipopolymer/siRNA Nanoparticles Targeting the Signal Transducer and Activator of Transcription 5A Disrupts Proliferation of Acute Lymphoblastic Leukemia;ACS Pharmacology & Translational Science;2024-08-15

2. A lineage-specific STAT5BN642H mouse model to study NK-cell leukemia;Blood;2024-06-13

3. Zinc as a potential regulator of the BCR-ABL oncogene in chronic myelocytic leukemia cells;Journal of Trace Elements in Medicine and Biology;2024-05

4. Ponatinib and STAT5 Inhibitor Pimozide Combined Synergistic Treatment Applications Potentially Overcome Drug Resistance via Regulating the Cytokine Expressional Network in Chronic Myeloid Leukemia Cells;Journal of Interferon & Cytokine Research;2024-04-01

5. The impact of the BCR-ABL oncogene in the pathology and treatment of chronic myeloid leukemia;Pathology - Research and Practice;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3